BETRF (BetterLife Pharma) Total Assets: $0.18 Mil (As of Apr. 2026)


BETRF BetterLife Pharma Inc BETRF
29 GF Score
Price $0.11
! 3 Warning Signs
View Full Analysis

What is BetterLife Pharma Total Assets?

BetterLife Pharma BETRF +13.20% 29 Total Assets is $0.18 Mil as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

BetterLife Pharma's Total Assets for the quarter that ended in Apr. 2026 was $0.18 Mil.

During the past 12 months, BetterLife Pharma's average Total Assets Growth Rate was -4.60% per year. During the past 3 years, the average Total Assets Growth Rate was 45.60% per year. During the past 5 years, the average Total Assets Growth Rate was -28.90% per year. During the past 10 years, the average Total Assets Growth Rate was 2.70% per year.

During the past 13 years, BetterLife Pharma's highest 3-Year average Total Assets Growth Rate was 632.50%. The lowest was -77.10%. And the median was 45.50%.

Total Assets is connected with ROA %. BetterLife Pharma's annualized ROA % for the quarter that ended in Apr. 2026 was -1,054.76%. Total Assets is also linked to Revenue through Asset Turnover. BetterLife Pharma's Asset Turnover for the quarter that ended in Apr. 2026 was 0.00.

BetterLife Pharma  (OTCPK:BETRF) Total Assets Explanation

Total Assets is connected with ROA %.

BetterLife Pharma's annualized ROA % for the quarter that ended in Apr. 2026 is

ROA %=Net Income (Q: Apr. 2026 )/( (Total Assets (Q: Jan. 2026 )+Total Assets (Q: Apr. 2026 ))/ count )
=-1.772/( (0.16+0.176)/ 2 )
=-1.772/0.168
=-1,054.76 %

Note: The Net Income data used here is four times the quarterly (Apr. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BetterLife Pharma's Asset Turnover for the quarter that ended in Apr. 2026 is

Asset Turnover
=Revenue (Q: Apr. 2026 )/( (Total Assets (Q: Jan. 2026 )+Total Assets (Q: Apr. 2026 ))/ count )
=0/( (0.16+0.176)/ 2 )
=0/0.168
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BetterLife Pharma Total Assets Related Terms

BetterLife Pharma Total Assets Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Total Assets Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 0.06 0.24 0.16 0.16

BetterLife Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26 Apr26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.17 0.17 0.16 0.18
BETRF
29GF Score
BetterLife Pharma Inc BETRF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BetterLife Pharma's Total Assets for the fiscal year that ended in Jan. 2026 is calculated as

Total Assets=Total Equity (A: Jan. 2026 )+Total Liabilities (A: Jan. 2026 )
=-4.71+4.87
=0.16

BetterLife Pharma's Total Assets for the quarter that ended in Apr. 2026 is calculated as

Total Assets=Total Equity (Q: Apr. 2026 )+Total Liabilities (Q: Apr. 2026 )
=-4.678+4.855
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.18 Mil mean?
BetterLife Pharma (BETRF) has a Total Assets of $0.18 Mil as of Apr. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's Total Assets too high?
BetterLife Pharma's current Total Assets is $0.18 Mil. Overall, BetterLife Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Total Assets compare to VRTX and REGN?
BetterLife Pharma's Total Assets of $0.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current Total Assets is $0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Total Assets of $0.18 Mil. The current Total Assets is $0.18 Mil. BetterLife Pharma's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Total Assets is $0.18 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
29GF Score

Get the complete analysis for BETRF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price